Growth Metrics

Galectin Therapeutics (GALT) EPS (Basic) Growth (3y) (2013 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Basic) Growth (3y) (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn - 139.68%
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn - -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn 25.99%
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn - -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn - 41.58%
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn 14.28%
7 Evaxion A 64.16 Bn 64.14 Bn - 58.35%
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn -2.92%
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn 45.92%
10 Galectin Therapeutics 165.77 Mn 151.67 Mn - 25.05%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 25.05%
Dec 31, 2025 23.69%
Sep 30, 2025 2.44%
Jun 30, 2025 9.14%
Mar 31, 2025 4.09%
Dec 31, 2024 -16.55%
Sep 30, 2024 -8.74%
Jun 30, 2024 -10.06%
Mar 31, 2024 -19.98%
Dec 31, 2023 -7.17%
Sep 30, 2023 -33.89%
Jun 30, 2023 -10.89%
Mar 31, 2023 -46.85%
Dec 31, 2022 -14.47%
Sep 30, 2022 -40.95%
Jun 30, 2022 -38.67%
Mar 31, 2022 5.27%
Dec 31, 2021 43.91%
Sep 30, 2021 -58.74%
Jun 30, 2021 -49.83%
Mar 31, 2021 -42.88%
Dec 31, 2020 -22.92%
Sep 30, 2020 8.37%
Jun 30, 2020 7.72%
Mar 31, 2020 26.32%
Dec 31, 2019 9.14%
Sep 30, 2019 32.14%
Jun 30, 2019 33.06%
Mar 31, 2019 5.90%
Dec 31, 2018 -52.96%
Sep 30, 2018 31.41%
Jun 30, 2018 36.15%
Mar 31, 2018 36.54%
Dec 31, 2017 25.60%
Sep 30, 2017 8.55%
Jun 30, 2017 6.27%
Mar 31, 2017 17.79%
Dec 31, 2016 -4.55%
Sep 30, 2016 10.07%
Jun 30, 2016 34.75%
Mar 31, 2016 -2.94%
Dec 31, 2015 -3.78%
Sep 30, 2015 -11.02%
Jun 30, 2015 -3.39%
Mar 31, 2015 -8.97%
Dec 31, 2014 16.31%
Sep 30, 2014 3.64%
Jun 30, 2014 20.63%
Mar 31, 2014 -4.00%
Dec 31, 2013 44.07%
Sep 30, 2013 -94.28%
Jun 30, 2013 -143.29%